share_log

We Think Zimmer Biomet Holdings' (NYSE:ZBH) Profit Is Only A Baseline For What They Can Achieve

We Think Zimmer Biomet Holdings' (NYSE:ZBH) Profit Is Only A Baseline For What They Can Achieve

我們認爲 Zimmer Biomet Holdings(紐約證券交易所代碼:ZBH)的利潤只是他們所能實現的目標的基準
Simply Wall St ·  02/15 06:25

Even though Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) recent earnings release was robust, the market didn't seem to notice. Our analysis suggests that investors might be missing some promising details.

儘管 Zimmer Biomet Holdings, Inc.s(紐約證券交易所代碼:ZBH)最近發佈的業績表現強勁,市場似乎沒有注意到。我們的分析表明,投資者可能遺漏了一些令人鼓舞的細節。

earnings-and-revenue-history
NYSE:ZBH Earnings and Revenue History February 15th 2024
紐約證券交易所:ZBH 收益和收入歷史記錄 2024 年 2 月 15 日

How Do Unusual Items Influence Profit?

不尋常的物品如何影響利潤?

Importantly, our data indicates that Zimmer Biomet Holdings' profit was reduced by US$200m, due to unusual items, over the last year. It's never great to see unusual items costing the company profits, but on the upside, things might improve sooner rather than later. We looked at thousands of listed companies and found that unusual items are very often one-off in nature. And, after all, that's exactly what the accounting terminology implies. Assuming those unusual expenses don't come up again, we'd therefore expect Zimmer Biomet Holdings to produce a higher profit next year, all else being equal.

重要的是,我們的數據表明,由於不尋常的項目,Zimmer Biomet Holdings的利潤比去年減少了2億美元。看到不尋常的項目使公司利潤損失從來都不是一件好事,但從好的方面來看,情況可能遲早會好轉。我們調查了數千家上市公司,發現不尋常的物品本質上往往是一次性的。而且,畢竟,這正是會計術語的含義。假設這些不尋常的支出不會再次出現,因此,我們預計Zimmer Biomet Holdings在其他條件相同的情況下,明年將實現更高的利潤。

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

這可能會讓你想知道分析師對未來盈利能力的預測。幸運的是,您可以單擊此處查看根據他們的估計描繪未來盈利能力的交互式圖表。

Our Take On Zimmer Biomet Holdings' Profit Performance

我們對Zimmer Biomet Holdings盈利表現的看法

Unusual items (expenses) detracted from Zimmer Biomet Holdings' earnings over the last year, but we might see an improvement next year. Based on this observation, we consider it likely that Zimmer Biomet Holdings' statutory profit actually understates its earnings potential! And on top of that, its earnings per share have grown at an extremely impressive rate over the last year. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. So if you'd like to dive deeper into this stock, it's crucial to consider any risks it's facing. While conducting our analysis, we found that Zimmer Biomet Holdings has 1 warning sign and it would be unwise to ignore it.

不尋常的項目(支出)減少了Zimmer Biomet Holdings去年的收益,但明年我們可能會看到改善。基於這一觀察,我們認爲Zimmer Biomet Holdings的法定利潤實際上可能低估了其盈利潛力!最重要的是,其每股收益在過去一年中以極其驚人的速度增長。歸根結底,如果你想正確地了解公司,必須考慮的不僅僅是上述因素。因此,如果你想更深入地研究這隻股票,那麼考慮它面臨的任何風險至關重要。在進行分析時,我們發現Zimmer Biomet Holdings有1個警告信號,忽視它是不明智的。

Today we've zoomed in on a single data point to better understand the nature of Zimmer Biomet Holdings' profit. But there is always more to discover if you are capable of focussing your mind on minutiae. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.

今天,我們放大了單一數據點,以更好地了解Zimmer Biomet Holdings利潤的性質。但是,如果你能夠將注意力集中在細節上,總會有更多的事情需要發現。例如,許多人認爲高股本回報率是有利的商業經濟的標誌,而另一些人則喜歡 “關注資金”,尋找內部人士正在買入的股票。因此,你可能希望看到這份免費收藏的擁有高股本回報率的公司,或者這份內部人士正在購買的股票清單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論